Delving into the Latest Updates on Baiziqian LifeI Zhike Granules with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Mechanism-

Therapeutic Areas

Infectious DiseasesRespiratory Diseases

Active Indication-

Inactive Indication

Acute Bronchitis

Originator Organization-

Active Organization-

Inactive Organization

Beijing University of Traditional Chinese MedicineDisha Group Weihai Disha Biological Products Co., Ltd.

Drug Highest PhaseSuspendedClinical

First Approval Date-

Regulation-

以安慰剂为对照，以咳嗽发作的持续天数（即从随机访视到最后一天患者日记卡上咳嗽次数>2 次的天数）为主要疗效指标，进一步验证百紫前利肺止咳颗粒治疗急性气管-支气管炎临床疗效。以临床症状、不良事件及实验室检查等指标，验证经7 天治疗后，百紫前利肺止咳颗粒治疗急性气管-支气管炎临床应用的安全性。

[Translation]

The clinical efficacy of Baiziqianlifeizhike granules in the treatment of acute tracheobronchitis was further verified by using placebo as the control and the duration of cough attacks (i.e. the number of days with >2 coughs on the patient's diary card from the random visit to the last day) as the main efficacy indicator. The safety of Baiziqianlifeizhike granules in the treatment of acute tracheobronchitis was verified by using indicators such as clinical symptoms, adverse events and laboratory tests after 7 days of treatment.

Start Date25 May 2015

Sponsor / Collaborator

Beijing University of Traditional Chinese Medicine

[+1]

100 Clinical Results associated with Baiziqian LifeI Zhike Granules

Login to view more data

100 Translational Medicine associated with Baiziqian LifeI Zhike Granules

Login to view more data

100 Patents (Medical) associated with Baiziqian LifeI Zhike Granules

Login to view more data

100 Deals associated with Baiziqian LifeI Zhike Granules

Login to view more data